Katrine Juhlin Kiørboe, Joana Serwaa Akoto, Morten Juhl Nørgaard, Merete Overgaard, Maria Niora, Krister Wennerberg, Kjeld Schmiegelow, Maria Thastrup
{"title":"A Comparative Study of Bone Marrow and Central Nervous System Microenvironment Models to Improve In Vitro Studies of Acute Lymphoblastic Leukemia","authors":"Katrine Juhlin Kiørboe, Joana Serwaa Akoto, Morten Juhl Nørgaard, Merete Overgaard, Maria Niora, Krister Wennerberg, Kjeld Schmiegelow, Maria Thastrup","doi":"10.1002/hon.70108","DOIUrl":null,"url":null,"abstract":"<p>The bone marrow (BM) niche plays a critical role in the development of acute lymphoblastic leukemia (ALL), while the central nervous system (CNS) is a common site of dissemination. Existing in vitro models of childhood ALL lack complexity and fail to recapitulate the <i>in vivo</i> microenvironments. This study aimed to improve ALL in vitro models by integrating key elements of the BM and CNS niches. We optimized the culture medium by evaluating the impact of cytokines and human platelet lysate in medium, which significantly improved ALL cell viability (<i>p</i> < 0.05) with a maximum viability of 54.61% achieved. Expression of cancer-associated fibroblast (CAF) markers in human Mesenchymal Stromal Cells (hMSCs) and human Meningeal Cells (HMCs) were examined, but co-culture with primary ALL cells did not induce an increase in CAF marker expression in our stromal cells. ALL cells exhibited enhanced viability in 5% oxygen compared to 21% oxygen (<i>p</i> < 0.05). The final BM and CNS models demonstrated superior survival of ALL cells (<i>p</i> < 0.05) compared to more simple models with a maximum viability achieved of 92.25% for BM model and 92.99% for CNS. These findings indicate that mimicking BM and CNS microenvironments enhances the survival of primary ALL cells in vitro.</p>","PeriodicalId":12882,"journal":{"name":"Hematological Oncology","volume":"43 4","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/hon.70108","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematological Oncology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/hon.70108","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The bone marrow (BM) niche plays a critical role in the development of acute lymphoblastic leukemia (ALL), while the central nervous system (CNS) is a common site of dissemination. Existing in vitro models of childhood ALL lack complexity and fail to recapitulate the in vivo microenvironments. This study aimed to improve ALL in vitro models by integrating key elements of the BM and CNS niches. We optimized the culture medium by evaluating the impact of cytokines and human platelet lysate in medium, which significantly improved ALL cell viability (p < 0.05) with a maximum viability of 54.61% achieved. Expression of cancer-associated fibroblast (CAF) markers in human Mesenchymal Stromal Cells (hMSCs) and human Meningeal Cells (HMCs) were examined, but co-culture with primary ALL cells did not induce an increase in CAF marker expression in our stromal cells. ALL cells exhibited enhanced viability in 5% oxygen compared to 21% oxygen (p < 0.05). The final BM and CNS models demonstrated superior survival of ALL cells (p < 0.05) compared to more simple models with a maximum viability achieved of 92.25% for BM model and 92.99% for CNS. These findings indicate that mimicking BM and CNS microenvironments enhances the survival of primary ALL cells in vitro.
期刊介绍:
Hematological Oncology considers for publication articles dealing with experimental and clinical aspects of neoplastic diseases of the hemopoietic and lymphoid systems and relevant related matters. Translational studies applying basic science to clinical issues are particularly welcomed. Manuscripts dealing with the following areas are encouraged:
-Clinical practice and management of hematological neoplasia, including: acute and chronic leukemias, malignant lymphomas, myeloproliferative disorders
-Diagnostic investigations, including imaging and laboratory assays
-Epidemiology, pathology and pathobiology of hematological neoplasia of hematological diseases
-Therapeutic issues including Phase 1, 2 or 3 trials as well as allogeneic and autologous stem cell transplantation studies
-Aspects of the cell biology, molecular biology, molecular genetics and cytogenetics of normal or diseased hematopoeisis and lymphopoiesis, including stem cells and cytokines and other regulatory systems.
Concise, topical review material is welcomed, especially if it makes new concepts and ideas accessible to a wider community. Proposals for review material may be discussed with the Editor-in-Chief. Collections of case material and case reports will be considered only if they have broader scientific or clinical relevance.